Investing.com — 在充满挑战的市场环境中，Myriad Genetics, Inc. (MYGN)股价触及52周低点，达到8.37美元。根据 InvestingPro 分析，该公司的RSI指标显示超卖状态，而基于公允价值计算，该股票似乎被低估。这一显著下跌反映了这家基因检测和精准医疗公司的更广泛趋势，其股价在过去一年中暴跌了-56.65%。尽管面临挑战，该公司在过去十二个月内实现了1 ...

Full Year 2024 Results Key Financial Results Revenue: US$11.0m (down 42% from FY ...

Dairy genetics have come so far that farmers breed for specific traits, including udder conformity, which governs udder depth ...

Investing.com — 在生物科技公司面临挑战的一年中，Atossa Genetics Inc. (ATOS)股票已触及新的52周低点，跌至0.66美元。根据 InvestingPro 数据显示，该公司保持强劲的流动性状况，当前比率为14.99，尽管分析师给出的目标价格在4美元至7美元之间。这家专注于开发肿瘤学和传染病治疗方案的公司股价大幅下跌，反映了整个板块的普遍回调。过去一年，Atos ...

Analysts have recently evaluated Myriad Genetics and provided 12-month price targets. The average target is $17.1, ...

Interestingly, we found that traumatic events and genetic factors can contribute independently to the risk of developing ...

Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental disorder that affects behaviour and social ...

近日，冰岛deCODE genetics公司（Amgen子公司）的科学家们发现，双相情感障碍与两个罕见的功能缺失变异有关。 这项研究成果于3月25日发表在《Nature Genetics》杂志上，有望协助人们开发出以此类基因为靶点的新型疗法，以避免长期使用现有疗法所带来的并发症。

Analysts at HC Wainwright reduced their FY2025 EPS estimates for shares of Opus Genetics in a research report issued to clients and investors on Tuesday, April 1st. HC Wainwright analyst M. Caufield ...

Autism Spectrum Disorder affects communication, social interaction, and behavior. Early diagnosis is crucial as it helps ...